Company news

Neumora Therapeutics, Inc. news in 2026

Neumora Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

August 14, 2026

Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026

July 27, 2026

Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update

June 15, 2026

Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference

May 12, 2026

Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

May 7, 2026

Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference

April 6, 2026

Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

March 29, 2026

Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026

March 15, 2026

Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026

February 4, 2026

Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones

January 5, 2026

Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer’s Disease Agitation

January 5, 2026

Calls in 2026

Decks in 2026